This product is a lyophilized peptide format.
Miscellaneous Medical/Legal Pitfalls: Misdiagnosis and the failure to diagnose are most commonly associated with nonpigmented oral malignant melanomas

Protocol 3: Comprehensive approach (advanced, with medical supervision) Goal: Full-spectrum immune modulation with organ support Phase 1 (Weeks 1-4): Foundation Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly BPC-157: 300 mcg subcutaneously, twice daily Phase 2 (Weeks 5-12): Add modulation Continue Phase 1 peptides Add KPV: 300-500 mcg subcutaneously, once daily Add Selank: 500 mcg intranasally, once daily Phase 3 (Weeks 13-16): Organ support cycle Continue Phase 2 peptides Add Thymalin: 10 mg course over 10 days Add targeted bioregulators based on affected organs (kidney, cardiac, vascular as needed) Phase 4 (Weeks 17-20): Rest and assess Discontinue all peptides Monitor disease activity markers Assess sustained benefits Plan next cycle based on results Monitoring: Full labs every 4 weeks, including CBC, CMP, complement levels, anti-dsDNA, CRP, ESR, urine protein/creatinine ratio

(Its important to note that the study doesnt explicitly state which kinds of GLP-1 drugs, such as Ozempic or Mounjaro, were administered.) They were also monitored against a control group
* Once the 2 syringes of water are in the vial in roll the vial between your fingers until dissolved (dont shake)
Xi'an Sonwu is looking forward to hearing from you